Buyer overview

AOK Sachsen - Anhalt

Germany

Find open notices with exactly the same buyer name and country.

Open notices in this group

47
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Ustekinumab (ATC: L04AC05)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
May 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jun 4, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Guselkumab (ATC: L04AC16)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
May 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jun 12, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Liraglutid (ATC: A10BJ02)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
May 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jun 18, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Somatropin (ATC: H01AC01)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jun 30, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jul 17, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Alitretinoin (ATC: D11AH04)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jun 30, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jul 17, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Midazolam (ATC: N03AE02)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jun 30, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jul 17, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Brivaracetam (ATC: N03AX23)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jun 30, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jul 17, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Golimumab (ATC: L04AB06)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jul 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Aug 5, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Tocilizumab (ATC: L04AC07)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jul 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Aug 5, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Rasagilin (ATC: N04BD02)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jul 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jul 24, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Natalizumab (ATC: L04AG03)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jul 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jul 24, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Vilanterol und Umeclidiniumbromid (ATC: R03AL03)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jul 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jul 24, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Nebivolol (ATC: C07AB12)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jul 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jul 24, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Irbesartan und Hydrochlorothiazid (ATC: C09DA24)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jul 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jul 24, 2026 View notice
Open TED DEU

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittel mit dem Wirkstoff Naproxen (ATC: M01AE02)

AOK Sachsen - Anhalt

The official notice does not provide a concise description in this language.

Deadline
Jul 31, 2028 00:00 UTC+02:00
Estimated value
Not announced
CPV 33600000Published Jul 24, 2026 View notice

Retained publications

The 20 most recent publications retained in Tenderiva, including open notices. This history is partial: a publication does not necessarily represent a distinct or awarded contract.

  1. Competition noticeTED

    Rahmenvertrag über die Lieferung von Verbrauchsmaterial und Zubehör sowie Serviceleistungen für MFPs

    640191-2026
  2. Competition noticeÖffentliche Vergabe

    Präventionsprojekt "Schulranzen-Check"

    25818514
  3. Competition noticeÖffentliche Vergabe

    Präventionsprojekt "Kleine Auszeit Kita"

    25818506
  4. Competition noticeÖffentliche Vergabe

    Präventionsprojekt "Kleine Auszeit im Hort"

    25818502
  5. Competition noticeÖffentliche Vergabe

    Präventionsprojekt "Bewegte Kita"

    25818490
  6. Competition noticeTED

    Präventionsprojekt "Bewegter Hort"

    633237-2026
  7. Competition noticeTED

    Arzneimittel mit dem Wirkstoff Perampanel (ATC: N03AX22)

    626248-2026
  8. Competition noticeTED

    Arzneimittel mit dem Wirkstoff Erythropoietin (ATC: B03XA01 - in der Wirkstärke über 10.000 IE je Dosiereinheit)

    618708-2026
  9. Competition noticeTED

    Arzneimittel mit dem Wirkstoff Follitropin alfa (ATC: G03GA05)

    618457-2026
  10. Competition noticeTED

    Arzneimittel mit dem Wirkstoff Macitentan (ATC: C02KX04)

    618417-2026
  11. Competition noticeTED

    Arzneimittel mit dem Wirkstoff Erythropoietin (ATC: B03XA01 - in der Wirkstärke bis 10.000 IE je Dosiereinheit)

    618090-2026
  12. Competition noticeTED

    Arzneimittel mit dem Wirkstoff Pegfilgrastim (ATC: L03AA13)

    616854-2026
  13. Result noticeTED

    Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Esperoct (B02BD02), NovoEight (B02BD02) und Alhemo (B02BX10) zur Behandlung der Hämophilie

    608945-2026
  14. Result noticeTED

    Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Kovaltry (B02BD02) und Jivi (B02BD02) zur Behandlung der Hämophilie

    608942-2026
  15. Result noticeTED

    Gewährung von Rabatten bei der Abgabe von Fertigarzneimitteln mit der Wirkstoffkombination Valsartan und Sacubitril (ATC-Code: C09DX04)

    608660-2026
  16. Result noticeTED

    Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Nuwiq (B02BD02), Octanate (B02BD02), Octanine F (B02BD04) und Wilate (B02BD06) bei Hämophilie

    608473-2026
  17. Result noticeTED

    Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Alprolix (B02BD04), Elocta (B02BD02) und Altuvoct (B02BD02) zur Behandlung der Hämophilie

    608423-2026
  18. Result noticeTED

    Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Benefix (B02BD04) und ReFacto AF (B02BD02) zur Behandlung der Hämophilie

    608195-2026
  19. Result noticeTED

    Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Haemate P (B02BD06) und Voncento (B02BD06) zur Behandlung der Hämophilie

    608165-2026
  20. Result noticeTED

    Arzneimittelrabattvertrag zu den Arzneimitteln Advate (B02BD02),Recombinate (B02BD02),Rixubis (B02BD04),Feiba (B02BD03),Immunate (B02BD06),Immuseven (B02BD05),Adynovi (B02BD02),Veyvondi (B02BD10)

    607562-2026